Skip to main content

Filippo Figini, MD

Original Contribution
06/04/2013
Despite the presence of complex distal left main lesions, new drug-eluting stents appear promising in the treatment of ULMCA disease in terms of safety and efficacy at 2-year clinical follow-up.
Despite the presence of complex distal left main lesions, new drug-eluting stents appear promising in the treatment of ULMCA disease in terms of safety and efficacy at 2-year clinical follow-up.
Despite the presence of complex...
06/04/2013
Journal of Invasive Cardiology
Original Contribution
08/29/2013
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the...
08/29/2013
Journal of Invasive Cardiology
Original Contribution
05/01/2016
Journal of Invasive Cardiology
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting
Original Contribution
09/01/2020
There is a lack of data on clinical outcomes of percutaneous coronary intervention with ultrathin stents on unprotected left main coronary artery comparing women and men. In our study, all patients treated with unprotected left main...
There is a lack of data on clinical outcomes of percutaneous coronary intervention with ultrathin stents on unprotected left main coronary artery comparing women and men. In our study, all patients treated with unprotected left main...
There is a lack of data on...
09/01/2020
Journal of Invasive Cardiology